| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |